Titlebook: Biomarkers in Breast Cancer; Giampietro Gasparini,Daniel F. Hayes Book 2006 Humana Press 2006 DNA.classification.gene expression.systemic

glamor

充足

形容詞詞尾

閃光東本

Assays for Gene AmplificationSince the approval of trastuzumab for the treatment of .-positive breast cancer (.), there has been an active debate as to the reproducibility and validity of the FDA-approved assays that detect . abnormalities in the tumor tissue. In this chapter, various clinical assays are compared focusing on practical issues.

arabesque

FLING

Biomarkers in Breast Cancer978-1-59259-915-8Series ISSN 2196-9906 Series E-ISSN 2196-9914

得意人

Guidelines for the Design of Clinical Studies for the Development and Validation of Therapeutically tic marker studies for breast cancer is inconsistent, and few such markers have been adopted for widespread use in clinical practice. This is problematic, as many patients are over-treated and many others are treated ineffectively. The deficiencies in clinical development of biomarkers may become mo

installment

Gene408

古代

Cell Kinetics in the past years many laboratories have set up and compared different approaches to measure the proliferation of tumor cells for clinical use. Although available results suggest that the majority of proliferation indices may help clinicians in treatment decision making, their clinical usefulness i